At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MGRX Mangoceuticals, Inc.
Pre-Mkt 12-23 04:15:23 EST
0.7830
+0.0700
+9.82%
High0.9800Low0.7000Vol5.06M
Open0.7131D1 Closing0.7130Amplitude39.27%
Mkt Cap12.05MTradable Cap9.12MTotal Shares15.39M
T/O4.37MT/O Rate43.42%Tradable Shares11.65M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Top Midday Decliners
MT Newswires Live  ·  12-20
Top Midday Decliners
Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results
Benzinga  ·  12-20
Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
GlobeNewswire  ·  12-19
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
BRIEF-Mangoceuticals Announces Partnership With The Cube Group
Reuters  ·  12-19
BRIEF-Mangoceuticals Announces Partnership With The Cube Group
Mangoceuticals Inc. Plans Up to $100 Million Solana-Focused Digital Asset Treasury Strategy with Cube Group, Targeting Yield Generation and Diversified Crypto Expansion
Reuters  ·  12-19
Mangoceuticals Inc. Plans Up to $100 Million Solana-Focused Digital Asset Treasury Strategy with Cube Group, Targeting Yield Generation and Diversified Crypto Expansion
Mangoceuticals, Inc. Announces Partnership With the Cube Group to Launch up to $100 Million Solana-Focused Digital Asset Treasury (Dat) Strategy
THOMSON REUTERS  ·  12-19
Mangoceuticals, Inc. Announces Partnership With the Cube Group to Launch up to $100 Million Solana-Focused Digital Asset Treasury (Dat) Strategy
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
GlobeNewswire  ·  12-18
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares
Reuters  ·  12-18
CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares
CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares
Reuters  ·  12-10
CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares
Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares
Reuters  ·  11-27
Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares
U.S. Stock Movement | "Partnership Clarification" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly
Stock News  ·  11-14
U.S. Stock Movement | "Partnership Clarification" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly
BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk
Reuters  ·  11-14
BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk
Mangoceuticals Inc: Mangoceuticals Has No Direct Contractual Relationship With Eli Lilly or Novo Nordisk
THOMSON REUTERS  ·  11-14
Mangoceuticals Inc: Mangoceuticals Has No Direct Contractual Relationship With Eli Lilly or Novo Nordisk
Mangoceuticals: via Mangorx Direct and Peaches Rx Direct, Co NOW Directly Offers Customers Eli Lilly and Novo Nordisk Glp-1 Medications
THOMSON REUTERS  ·  11-14
Mangoceuticals: via Mangorx Direct and Peaches Rx Direct, Co NOW Directly Offers Customers Eli Lilly and Novo Nordisk Glp-1 Medications
BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA
Reuters  ·  11-14
BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA
Novo Nordisk, Eli Lilly Spokespeople Say the Companies Have No Affiliation With Telehealth Platform Mangoceuticals, in Response to Its Press Release on Weight-Loss Partnerships
THOMSON REUTERS  ·  11-14
Novo Nordisk, Eli Lilly Spokespeople Say the Companies Have No Affiliation With Telehealth Platform Mangoceuticals, in Response to Its Press Release on Weight-Loss Partnerships
Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform
MT Newswires Live  ·  11-13
Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform
Mangoceuticals Shares up 48% Premarket After Co Partners With Eli Lilly and Novo Nordisk to Sell Weight-Loss Drugs
THOMSON REUTERS  ·  11-13
Mangoceuticals Shares up 48% Premarket After Co Partners With Eli Lilly and Novo Nordisk to Sell Weight-Loss Drugs
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
Reuters  ·  11-13
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
Mangoceuticals Partners With Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
THOMSON REUTERS  ·  11-13
Mangoceuticals Partners With Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management

Introduction

Company Name.
Mangoceuticals, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Issue price:
--